Cell-specific responses to loss of cyclin-dependent kinases

C Berthet1, P Kaldis

  • 1Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702-1201, USA.

Oncogene
|February 14, 2007
PubMed

Insights

Cell cycle regulation shows surprising Cdk/cyclin compensation in most cells, but differentiated and tumor cells are more sensitive to Cdk loss, offering cancer therapy insights.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Cyclin-dependent kinases (Cdks) and cyclins are crucial regulators of the cell cycle.
  • Inactivating Cdks in mice revealed unexpected resistance and compensation mechanisms in various cell types.

Purpose of the Study:

  • To elucidate cell-type specific differences in cell cycle regulation.
  • To explore the potential of targeting Cdk activity for cancer therapy.

Main Methods:

  • Review of existing literature on Cdk/cyclin inactivation studies in mice.
  • Comparative analysis of cell cycle regulation across embryonic, differentiated, stem, and tumor cells.

Main Results:

  • General cell resistance to Cdk loss suggests significant compensatory pathways.
  • Early embryonic cells exhibit low sensitivity to multiple Cdk/cyclin deficiencies.
  • Differentiated and tumor cells show greater dependence on Cdk/cyclin complexes and limited functional redundancy.

Conclusions:

  • Cell-type specific differences in cell cycle regulation are critical.
  • Tumor cells, while sharing proliferative traits with stem cells, are more susceptible to Cdk inhibition, resembling differentiated cells.
  • Understanding these sensitivities can guide the development of targeted cancer therapies.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...